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During development, epithelial cells need a little help fi  guring out which way is up.  <addart type=”rel” doi=”10.1083/jcb.200807121”>Jaffe et al. </addart> show 
how a polarizing protein ensures that the cells face the right direction.
A newborn epithelial cell in, say, the intestinal lining will polarize so that its apical surface is 
oriented toward the gut lumen. The protein Cdc42 helps set up polarity in a range of organisms and 
cell types, and previous studies suggested that it does the same in epithelial cells. The mechanism 
remained obscure, however.
To determine how Cdc42 differentiates top from bottom, Jaffe et al. grew human intestinal 
cells in a three-dimensional culture. The cells divided repeatedly to form a sphere, with their apical 
surfaces directed toward a central lumen.
When the researchers used RNAi to slash Cdc42 levels, they expected the cells to become 
symmetric. Instead, the cells polarized, but they clustered around multiple lumens. That result 
indicates that rather than instigating polarization, Cdc42 determines where it occurs.
Cdc42 orients cells by helping position the mitotic spindle so that it is perpendicular to the 
middle of the sphere. Thus, division splits each cell radially, and the apical surface of each daughter 
remains in the center of the cluster. If Cdc42 is missing, the spindle orients randomly, and the apical 
surface of a particular daughter cell can end up outside the center—hence, the extra lumens.
The researchers also found that the apical surface forms at the last point of contact between 
dividing cells. They showed that the midbody, the tether between daughter cells, is located 
asymmetrically so that all apical surfaces form at the center of the cluster. Determining whether 
Cdc42 controls midbody position will require further research.
Jaffe, A.B., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200807121.
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Before they can get down to killing a cell, apoptosis-promoting caspase-8 enzymes must socialize.  <addart type=”rel” doi=”10.1083/jcb.200803129”>Gonzalvez 
et al. </addart> reveal that a mitochondrial lipid provides a gathering place where the enzymes can mingle.
After receiving an external death signal, cells can commit suicide in several ways. In one 
mechanism, inactive copies of caspase-8 gather at the death-inducing signaling complex (DISC) on 
the cell membrane. There, the molecules combine and cut one another, becoming active enzymes.
But in an alternative mechanism, Gonzalvez et al. showed that caspase-8 migrates to the mitochondria 
instead of combining at the DISC. While probing the function of cardiolipin, a mitochondrial membrane 
lipid, Gonzalvez et al. discovered how caspase-8 molecules meet up at this organelle.
The researchers tested cells from patients with Barth syndrome, a rare genetic disorder in which 
the functional form of cardiolipin is scarce. The cells survived treatment with apoptosis-triggering 
molecules such as TNF. Without mature cardiolipin, caspase-8 doesn’t embed in the mitochondrial 
membrane and doesn’t get activated, the scientists found.
Cardiolipin seems to serve as the mitochondrial equivalent of the DISC, a platform where 
caspase-8 molecules can collect and undergo the modifi  cations necessary for activation. Still unclear 
is what signal directs caspase-8 to the mitochondria and whether other caspases also travel to the 
organelles to be switched on.
Gonzalvez, F., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200803129.
Epithelial cells are already polarized 
by the ﬁ  rst division, as indicated by 
the presence of the apical marker 
ZO-1 (red) on the cells’ inner surfaces.
Caspase-8 (red) normally homes in 
on mitochondria (green) but diffuses 
widely when mature cardiolipin is 
absent (right).
After removal of ankyrinG, this 
axon (arrows) grew a stubble of 
dendritic spines.
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Inside every axon is a dendrite waiting to get out.  <addart type=”rel” doi=”10.1083/jcb.200806112”>Hedstrom et al. </addart> converted mature axons into 
dendrites by banishing a protein crucial for neuron development. The results suggest that this 
transformation could occur after nerve cell damage.
At the junction between the axon and the cell body is the axon initial segment (AIS), which sparks 
action potentials. Researchers also suspect that the AIS enables an axon to maintain its identity. Although 
scientists have teased out some of the molecular events that determine whether a neuron outgrowth will 
become an axon or a dendrite, they know little about what keeps these structures distinct.
In cultured neurons, Hedstrom et al. used RNAi to cut production of ankyrinG, a protein that helps 
spur formation of the AIS. Loss of ankyrinG caused the AIS to disappear. For example, sodium channels IN THIS ISSUE • THE JOURNAL OF CELL BIOLOGY 569
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that normally crowd the AIS’s plasma membrane dispersed. When ankyrinG was absent the erstwhile 
axons began to resemble dendrites, sprouting spines and developing excitatory synapses. Characteristic 
molecules from the cell body and dendrites, such as the microtubule polymerizing protein MAP2, also 
infi  ltrated the axons.
The AIS appears to serve as a fi  lter that screens out dendritic proteins, Hedstrom et al. conclude. 
How the structure bars some proteins from the axon is still uncertain. Injuries and diseases can 
transform dendrites into axons. The fi  ndings raise the possibility that these insults could cause the 
reverse transformation by changing the amount of ankyrinG and altering the AIS.
Hedstrom, K.L., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200806112.
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<addart type=”rel” doi=”10.1083/jcb.200804041”>Aucott et al. </addart> report the fi  rst in vivo experiments on the heterochromatin protein 1 (HP1) family, which 
sidles up to silent DNA. The results add to the evidence that the different versions of the proteins help 
cells fi  x broken DNA.
The function of HP1 proteins has puzzled researchers. The proteins, which come in three forms 
in mammals, cozy up to heterochromatin—the tightly wound sections of DNA where genes are 
usually inactive. Early studies indicated that the proteins’ job was to turn genes off. But recent work 
suggested that the proteins are essential for repairing damaged DNA. These results came from in vitro 
studies, however, and the proteins’ powers in vivo remained uncertain.
Aucott et al.  created the fi  rst mouse strain missing one of the HP1 versions, HP1. The animals 
die shortly after birth because their lungs don’t infl  ate. The rodents show brain defects as well. 
Large numbers of neurons die, for example, and the neural stem cells in the cortex divide sluggishly. 
Both effects could arise from unfi  xed DNA. When the researchers grew brain cells from HP1-
lacking mice in culture, they saw clear indications of genomic instability that can result from faulty 
DNA repair, including unpaired sister chromatids that separated prematurely and even extra sets of 
chromosomes. The HP1 proteins latch onto the methylated version of the H3 histone, but how this 
interaction promotes repair is an unanswered question.
Aucott, R., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200804041.
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A colon cancer cell isn’t a lost cause. Vitamin D can tame the rogue cell by adjusting everything from 
its gene expression to its cytoskeleton.  <addart type=”rel” doi=”10.1083/jcb.200803020”>Ordóñez-Morán et al. </addart> show that one pathway governs the 
vitamin’s diverse effects. The results help clarify the actions of a molecule that is undergoing clinical 
trials as a cancer therapy.
Vitamin D stymies colon cancer cells in two ways. It switches on genes such as the one that 
encodes E-cadherin, a component of the adherens junctions that anchor cells in epithelial layers. 
The vitamin also induces effects on the cytoskeleton that are required for gene regulation and 
short-circuiting the Wnt/-catenin pathway, which is overactive in most colon tumors. The net 
result is to curb division and prod colon cancer cells to differentiate into epithelial cells that settle 
down instead of spreading.
To delve into the mechanism, the team dosed colon cancer cells with calcitriol, the metabolically 
active version of vitamin D. Calcitriol triggered a surge of calcium into the cells and the subsequent 
switching on of RhoA–RhoGTPases, which have been implicated in the cytoskeletal changes induced 
by vitamin D. The activated RhoA in turn switched on one of its targets, the rho-associated coiled 
kinase (ROCK), which then roused two other kinases. Each step in this nongenomic pathway was 
necessary to spur the genomic responses, the researchers showed. The team also nailed down the 
contribution of the vitamin D receptor (VDR). The receptor was crucial at the beginning of the pathway, 
where it permitted the calcium infl  ux, and at the end, where it activated and repressed genes.
The study is the fi  rst to show that vitamin D’s genomic and nongenomic effects integrate to 
regulate cell physiology. One question the researchers now want to pursue is whether VDR from 
different locations—the nucleus, the cytosol, and possibly the cell membrane—has different functions 
in the pathway.
Ordóñez-Morán, P., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200803020.
Extra chromosomes crowd a polyploid 
cell from a mouse lacking HP1.
Vitamin D spurs cancer cells to 
take on the spread-out epithelial 
phenotype (left), but they are more 
rounded if RhoA is disrupted (right).